Close
iStaging reveals Next Generation MR experiences at VivaTech 2024. May 23, 2024 10:18PM

TAIPEI, Taiwan--(BUSINESS WIRE)-- iStaging is an innovative Mixed Reality SaaS company driven by computer vision & AI, backed by 10 years of technological development and 100,000 corporate users around the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240522635432/en/

iStaging reveals Next Generation MR experiences at VivaTech 2024 (Photo: Business Wire)

iStaging joined VivaTech this year to... (continue reading...)


Mitsubishi Electric to Establish Vietnamese JV for FA Products May 23, 2024 10:10PM

Will initially produce low-voltage circuit breakers for factory-automation products in ASEAN region

TOKYO--(BUSINESS WIRE)-- Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it will acquire an 80% stake in Fuji Bakelite Vietnam Co., Ltd. in outskirts of Hanoi, a subsidiary of Fuji Bakelite Co., Ltd. in Okayama Prefecture, Japan. The new joint venture (JV) company, to be named Mitsubishi Electric FP Automation Vietnam Co., Ltd., will be... (continue reading...)


The World's First Five-Terminal Flexible DC Transmission Project is Undergoing a Complete Overhaul May 23, 2024 09:42PM

ZHEJIANG, Zhoushan--(BUSINESS WIRE)-- On May 17, in Zhoushan, Zhejiang Province, the world's first five-terminal flexible DC transmission project, Zhoushan five-terminal VSC-HVDC transmission project, is undergoing a complete overhaul for the first time after it was put into operation. Aeroamphibious intelligent equipment and advanced technology are used in this overhaul, in order to greatly enhance working efficiency by decreasing the overhaul duration in the... (continue reading...)


Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe May 23, 2024 09:26PM
  • Omlyclo® (CT-P39), used to treat allergic asthma, chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic spontaneous urticaria (CSU), becomes the first omalizumab biosimilar approved in the European Union
  • The European Commission (EC) decision is based on clinical evidence, including results from a Phase III clinical trial demonstrating a comparable efficacy and safety profile with the reference product Xolair®
  • Omlyclo® is the first omalizumab... (continue reading...)

The 2024 ESSENCE Festival of Culture™ Celebrates 30 Years of Loving Us with Evening Performances from USHER for a Special One-Night Only 20th Anniversary of Confessions Milestone Moment, Janet Jacks May 23, 2024 08:53PM

NEW ORLEANS--(BUSINESS WIRE)--

 

The 2024 ESSENCE Festival of Culture™ Celebrates 30 Years of Loving Us with Evening Performances from USHER for a Special One-Night Only 20th Anniversary of Confessions Milestone Moment, Janet Jackson, Charlie Wilson, Victoria Monét, Birdman & Friends Presents 30 Years of Cash Money Millionaires, A Special Passing of the Torch by Frankie Beverly & Maze and more!

Legacy will take center stage as the 2024 ESSENCE Festival of... (continue reading...)


More Business Wire

View Older Stories

May 23, 2024 08:39PM Lee Leads Wire-to-Wire to Win MLF General Tire Heavy Hitters 2024 Presented by Bass Pro Shops on the Kissimmee Chain of Lakes
May 23, 2024 08:09PM Alibaba Group Prices US$4,500 Million Offering of Convertible Senior Notes
May 23, 2024 07:35PM Sensedia Launches AI Copilot to Accelerate and Enhance API Development
May 23, 2024 07:03PM FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option
May 23, 2024 06:56PM Limbach Holdings to Participate in Stifel Conference
May 23, 2024 06:12PM FCPT Announces Sale Leaseback of Eight Mavis Tire Operated Properties for $20 Million
May 23, 2024 06:00PM Aqua Pennsylvania Files Rate Request Based on Water and Wastewater Operations, Infrastructure Improvements and Repairs Across the Commonwealth
May 23, 2024 05:58PM Browning West Announces Successful Replacement of Gildan Activewear’s Entire Board of Directors with Full Eight-Member Slate
May 23, 2024 05:42PM Golden Entertainment Announces Repricing of Term Loan
May 23, 2024 05:32PM Luskin Orthopaedic Institute for Children (LuskinOIC) Stand For Kids Gala Honors the Los Angeles Chargers and Students Run LA on the 50-yard Line of SoFi Stadium on June 8, 2024
May 23, 2024 05:30PM Power Integrations to Present at Upcoming Investor Conferences
May 23, 2024 05:25PM SSR Mining Announces Voting Results From 2024 Annual and Special Meeting of Shareholders
May 23, 2024 05:23PM Pan American Silver Releases 2023 Sustainability Report
May 23, 2024 05:21PM Crypto Specialist Bitwise’s First-Ever Spot Ethereum ETF Receives Key SEC Approval
May 23, 2024 05:20PM Pei enters the MSCI COLCAP index
May 23, 2024 05:18PM Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts to its Data Centers
May 23, 2024 05:15PM Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
May 23, 2024 05:15PM Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2024 Annual Meeting
May 23, 2024 05:15PM NW Natural Holdings and NW Natural CEO David H. Anderson Announces Retirement
May 23, 2024 05:12PM Nimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual Meeting
May 23, 2024 05:10PM Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
May 23, 2024 05:10PM Barnes & Noble Education Announces Preliminary Fiscal Year 2024 Results
May 23, 2024 05:05PM Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel
May 23, 2024 05:05PM Aulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual Meeting
May 23, 2024 05:05PM TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany
May 23, 2024 05:05PM Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
May 23, 2024 05:05PM TelevisaUnivision Announces Pricing of $1.0 Billion Debt
May 23, 2024 05:04PM BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Declares Distribution
May 23, 2024 05:02PM KBRA Assigns AAA Rating, Stable Outlook to the New Mexico Finance Authority State Transportation Revenue Refunding Bonds (State Transportation Commission - Senior Lien), Series 2024A
May 23, 2024 05:02PM Stellar Bancorp, Inc. Declares Quarterly Dividend and New Share Repurchase Program
May 23, 2024 05:01PM Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First
May 23, 2024 05:01PM NMDP and CIBMTR to Present New, Promising Stem Cell Transplantation Trial Data using Mismatched, Unrelated Donors at 2024 ASCO Annual Meeting
May 23, 2024 05:00PM Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting
May 23, 2024 05:00PM Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:00PM SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
May 23, 2024 05:00PM Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
May 23, 2024 05:00PM Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
May 23, 2024 05:00PM Xspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than expected negative effects on the bioavailability of crystalline dasatinib
May 23, 2024 05:00PM City of Hope Researchers to Present Investigational Treatments for Colorectal, Kidney and Blood Cancers at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:00PM Obsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:00PM Comvest Partners Announces $70 Million Senior Credit Facility For Nationwide Energy Partners to Support Growth Strategy
May 23, 2024 05:00PM EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
May 23, 2024 05:00PM NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Socie
May 23, 2024 05:00PM AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid Cancer
May 23, 2024 05:00PM Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
May 23, 2024 05:00PM Incendia Therapeutics Announces Upcoming Presentation with PathAI at the 2024 American Society of Clinical Oncology Annual Meeting
May 23, 2024 05:00PM Klaviyo to Present at the William Blair Growth Stock Conference
May 23, 2024 05:00PM Dentalcorp Announces Annual General Meeting Voting Results
May 23, 2024 04:59PM Ligand to Participate in Upcoming Investor Conferences
May 23, 2024 04:40PM Genworth Financial Announces Results of Annual Meeting
View Older Stories